U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C6H7O6.Mg
Molecular Weight 374.5379
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MAGNESIUM ASCORBATE

SMILES

C([C@@]([H])([C@]1([H])C(=C(C(=O)O1)O)O)O)O.C([C@@]([H])([C@]1([H])C(=C(C(=O)O1)[O-])[O-])O)O.[Mg+2]

InChI

InChIKey=AIOKQVJVNPDJKA-ZZMNMWMASA-L
InChI=1S/2C6H8O6.Mg/c2*7-1-2(8)5-3(9)4(10)6(11)12-5;/h2*2,5,7-10H,1H2;/q;;+2/p-2/t2*2-,5+;/m00./s1

HIDE SMILES / InChI

Description
Sources: DOI: 10.2903/j.efsa.2009.994
Curator's Comment:: description was created based on several sources, including: http://www.xtend-life.com/information/ingredients/magnesium_ascorbate

Magnesium ascorbate is a non-acidic buffered form of Vitamin C and a source of the essential mineral Magnesium. The in vitro model system consisted of the isolated section of rat small intestine. The sources of magnesium ion (Mg2+) were magnesium chloride, magnesium sulphate, magnesium acetate, magnesium lactate, magnesium hydrocitrate and magnesium ascorbate. Magnesium ions from magnesium ascorbate were absorbed after the first 15 minutes to the highest extent of all salts, but after 120 minutes their absorption was the smallest of all. The use of magnesium ascorbate in food supplements may lead to an additional exposure to vitamin C and Magnesium.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Magnesium Ascorbate

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Magnesium ascorbate in anesthesiological practice; clinico-experimental study].
1955 Nov
[CLINICAL RESEARCH ON THE SEPARATE AND COMBINED ACTION OF QUINIC ACID AND MAGNESIUM ASCORBATE IN 64 CASES OF HYPERAZOTEMIA].
1963 Jul-Aug
Morphophysiological studies in experimental myocardial stress induced by isoproterenol. Note II. The myocardioprotector effect of magnesium ascorbate.
1984 Jan-Mar
Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
2005
Patents

Sample Use Guides

In Vivo Use Guide
Sources: http://www.sourcenaturals.com/products/GP1414 DOI: 10.2903/j.efsa.2009.994
1 g twice daily (70 mg/magnesium/person/day)
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
MAGNESIUM ASCORBATE
INCI   WHO-DD  
INCI  
Official Name English
MAGNESIUM ASCORBATE [INCI]
Common Name English
L(+)-ASCORBIC ACID MAGNESIUM SALT
Common Name English
ASCORBIC ACID, MAGNESIUM SALT
Common Name English
MAGNESIUM ASCORBATE [WHO-DD]
Common Name English
VITAMIN C MAGNESIUM SALT
Common Name English
Classification Tree Code System Code
DSLD 2918 (Number of products:35)
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
Code System Code Type Description
FDA UNII
0N1G678593
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY
ECHA (EC/EINECS)
239-442-6
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY
PUBCHEM
16211196
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY
DRUG BANK
DB14484
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY
RXCUI
1311396
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY RxNorm
EVMPD
SUB03009MIG
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY
CAS
15431-40-0
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY
EPA CompTox
15431-40-0
Created by admin on Sat Jun 26 16:27:21 UTC 2021 , Edited by admin on Sat Jun 26 16:27:21 UTC 2021
PRIMARY